Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Phase 2
2(40.0%)
Phase 3
1(20.0%)
5Total
N/A(2)
Phase 2(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03269357Not ApplicableCompleted

LARC Forward Counselling

Role: lead

NCT01615224Phase 2Terminated

Repeated Doses of Misoprostol for Medical Treatment of Missed Miscarriage

Role: lead

NCT01615211Phase 2Terminated

Randomized Study of Letrozole and Trilostane for Medical Abortion

Role: lead

NCT01617564Not ApplicableCompleted

Paracervical Block During II-trimester Abortion

Role: lead

NCT01612923Phase 3Completed

Safety and Efficacy of Medical Abortion Provided by Midlevel Providers or Physicians

Role: lead

All 5 trials loaded